Trial intelligence / Profile preview

Levofloxacin in multi-drug-resistant tuberculosis

NCT00495339Phase 4Completed

Sponsor
Sanofi
Start
Jun 2007
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levofloxacin in Tuberculosis (TB), sponsored by Sanofi. Started Jun 2007; status: completed.

02

Drugs

levofloxacin
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT00495339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00495339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call